Solid Biosciences Inc. (SLDB)

Solid Biosciences Inc (NASDAQ:SLDB) is one of the best gene therapy stocks to buy in 2026.

Solid Power director Lesa Roe sold 39,207 shares at $2.66 under a 10b5-1 plan and received 44,133 restricted stock units, ending with 283,182 shares.

Solid Power director Steven H. Goldberg received 44,133 stock units, raising his direct holdings to 162,941 shares and units, with vesting tied to service and settlement deferred.

Solid Power, Inc. (NASDAQ:SLDP – Get Free Report) Director Lesa Roe sold 39,207 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $2.66, for a total value of $104,290.62. Following the sale, the director owned 243,975 shares ...

Solid Biosciences’ Q1 2026 net loss reached $56.7M as R&D rose to $46.1M. Cash, cash equivalents and available-for-sale securities totaled $380.7M, expected to fund operations into the first half of 2028.